As the COVID-19 pandemic has fueled people’s interest in immunity, a growing number of people are buying red ginseng as a gift for Lunar New Year's Day.The reason why red ginseng is popular as a gift during holidays is that it is a health enhancement gift. Red ginseng is a health functional food
With the COVID-19 pandemic still gripping the world, interest in boosting immunity has been on the uptick. Strengthening the immune system is as important as personal hygiene for fighting viruses and germs.In Korea, the most popular immunity booster is red ginseng. The immunity boosting effects of r
The Korea Basic Science Institute (KBSI) announced on Jan. 6 that its research team led by Dr. Kang Hyun-oh and Korea Advanced Institute of Science and Technology (KAIST) professor Park Chan-bum’s research team developed a nanocomposite capable of suppressing amyloid plaque formation.The nanocomposi
Samsung Biologics has decided to stop the research and development (R&D) activities of Archigen Biotech, a joint venture with AstraZeneca.Archigen Biotech, launched in 2014, has been developing “SAIT101,” a biosimilar of Rituxan (component name: Rituximab). Rituxan is a biopharmaceutical product of
The Korean drone market has already been dominated by foreign drones. Drones made by DJI of China as toys and for leisure activities account for more than 60 percent of Korea's drone market. They also account for more than 70 percent of the industrial drone market in Korea. DJI, the world's
KT Corp., South Korea's largest telecommunications company, is diversifying its business from robotics to digital health as part of efforts to develop new growth engines in the next era of connectivity, media and other transformative industries.In the latest move, KT has signed a memorandum of u
The author is an analyst of NH Investment & Securities. He can be reached at william.ku@nhqv.com. -- Ed. Having signed a CMO contract with CEPI, GC Pharma should see its earnings make a quantum leap in 1H21 on the start of related supply. Reflecting a value of W2.86tn for the CMO contract, we raise
ViGenCell, a biotechnology affiliate of Boryung Pharmaceutical that specializes in immune cell therapy technologies, has launched a scientific advisory committee composed of immunological and clinical research experts to accelerate the development of treatments for intractable diseases and strengthe
The author is an analyst of NH Investment & Securities. He can be reached at william.ku@nhqv.com. -- Ed. Structural earnings growth should be on the way thanks to both increased domestic flu vaccine sales and the planned 1H21 launch of Hunterase in China. Similar to 11 years ago in the wake of the 2
The author is an analyst of NH Investment & Securities. He can be reached at william.ku@nhqv.com. -- Ed. With Sanofi confirming its decision to return the rights for Efeglenatide, we expect Hanmi to book unpaid R&D expenses in its accounting, leading to a large-scale operating loss in 3Q20. We maint
GC Medical Science (GC MS), a company specializing in diagnostic reagents and medical devices, announced on Oct. 6 that it has clinched export deals worth US$19 million from two European companies.The company signed a contract with Handprod, a Polish company, to supply US$11 million worth of blood g
The author is an analyst of NH Investment & Securities. He can be reached at ryan.ra@nhqv.com. – Ed. Ilooda boasts a profit structure in which its margins improve in line higher equipment sales and greater frequency of procedures and the resultant rise in medical consumables sales. Having secured a
KT announced on Sept. 25 that it has signed a business agreement with NGeneBio to jointly develop and commercialize digital healthcare services based on genetic information analyses.NGeneBio started as KT's first in-house venture startup specializing in R&D, reagent production, software R&D and
The Ulsan National Institute of Science and Technology (UNIST) announced on Sept. 23 that its research team led by biomedical engineering professor Kang Joo-hun developed a micro fluid chip for rapid detection of viral and bacterial infections.According to the team, the thumb-size chip has a tube as
Daewoong Pharmaceutical announced the results of a phase 2 clinical trial of SGLT-2 diabetes treatment Enavogliflozin at the 2020 International Conference on Diabetes and Metabolism (ICDM) which was held from Sept. 18-19.The ICDM was hosted by the Korean Diabetes Association. It marked its 10th anni
Boryung Pharmaceutical's new high blood pressure drug Tubero (a composite drug for dyslipidemia), which belongs to the company’s Kanarb family of hypertension drugs, made its debut in the Mexican market on Sept. 11 (Korea time).Tubero is Boryung’s fourth product to be introduced in Mexico, follo
Boryung Pharmaceutical and Vigencell announced on Sept. 8 that they have signed an R&D agreement to develop immunocyte therapy. The agreement will pave the way for the two companies to cooperate in development and commercialization of diverse immune-cell treatments.The agreement will help Vigencell
JP Morgan has marked down Celltrion’s target share price to 60 percent of the current level.Celltrion closed at 298,000 won on Sept. 9, down 6.13 percent from the previous day. Foreign investors and institutional investors net-sold Celltrion shares worth 44.7 billion won and 56 billion won, respecti
GC Cell announced on Sept. 7 that it will invest US$4.2 million in Novacell, its wholly owned U.S. subsidiary, and start a full-scale clinical trial of MSLN-CAR-T under development in the United States.Early this year, GC Cell confirmed a 100-percent elimination of pancreatic cancer cells through an
Professor Yoon Dae-sung at the Korea University School of Biomedical Engineering and professor Hwang Kyo-seon at the Department of Clinical Pharmacology of Kyung Hee University announced on Aug. 31 that their research team has developed a graphene-based field-effect transistor platform and their hig